EU cross-border healthcare directive will have fundamental impact on medtech industry
This article was originally published in SRA
Executive Summary
The EU's directive on the application of patients' rights in cross-border healthcare will have a fundamental impact on the medtech market of the future1,2. New structures created by the directive will particularly affect the areas of health technology assessment, e-health and the co-ordination of healthcare specialisations, particularly for rare diseases.